CookiesThis site uses cookies to analyze site interaction in order to improve the quality of service and ensure smooth operation of the site. In more detail in Cookies policy
A specialized edition intended for medical institutions and doctors.

"No Shortage of medicines in Ukraine, and pharmaceutical industry is about to reach the pre-war level", - Dmytro Shymkiv for Media Center Ukraine

There is no shortage of medicines in Ukraine. Dmytro Shymkiv, Chair of the Board of Directors of Darnitsa Group Pharma Company, made this statement during his briefing at Media Center Ukraine.

According to him, there may be occasional supply issues with some medicines.

“The supply of some foreign medicines is limited due to complex logistics chains. However, the medicines produced by Ukrainian pharmaceutical companies can meet all needs of Ukraine’s population. So, any deficit of medicines is out of the question,” Shymkiv explained.

The prospects of the pharmaceutical industry of Ukraine were also discussed at the briefing. According to Dmytro Shymkiv, Ukraine can become a global hub for supplying not only foods but also pharmaceuticals, for instance, to countries of Eastern Europe and the Middle East. Ukraine’s pharmaceutical industry has enough production capacity to supply medicines to Ukrainian and international consumers. Moreover, the development of new medicines has not been stopped even after russia’s all-out invasion.

“Darnitsa Group produced four new medicines in March and April. Seven more are to come in June. On March 18, we were licensed to develop and manufacture Pfizer’s Paxlovid, a drug against Covid-19. We may sell it to 95 countries around the world. In April, the WHO decided to select Darnitsa Group as the only platform in Ukraine eligible for implementing mRNA-based drug manufacture technologies that are used not only for vaccines but also for promising medicines. It will help bring the modern technologies closer to consumers – first of all, the Ukrainian consumers,” Dmytro Shymkiv explained.